Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells.
Publication
, Conference
Morse, M; Hobeika, A; Osada, T; Berglund, P; Negri, S; Niedzwiecki, D; Hubby, B; Burnett, BK; Clay, TM; Lyerly, HK
Published in: Journal of Clinical Oncology
May 20, 2010
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
2544 / 2544
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Morse, M., Hobeika, A., Osada, T., Berglund, P., Negri, S., Niedzwiecki, D., … Lyerly, H. K. (2010). Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells. In Journal of Clinical Oncology (Vol. 28, pp. 2544–2544). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.2544
Morse, M., A. Hobeika, T. Osada, P. Berglund, S. Negri, D. Niedzwiecki, B. Hubby, B. K. Burnett, T. M. Clay, and H. K. Lyerly. “Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells.” In Journal of Clinical Oncology, 28:2544–2544. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.2544.
Morse M, Hobeika A, Osada T, Berglund P, Negri S, Niedzwiecki D, et al. Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 2544–2544.
Morse, M., et al. “Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. 2544–2544. Crossref, doi:10.1200/jco.2010.28.15_suppl.2544.
Morse M, Hobeika A, Osada T, Berglund P, Negri S, Niedzwiecki D, Hubby B, Burnett BK, Clay TM, Lyerly HK. Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 2544–2544.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
2544 / 2544
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences